USANA Health Valuation
| USNA Stock | USD 27.31 0.23 0.84% |
At this time, the company appears to be undervalued. USANA Health Sciences owns a latest Real Value of $32.88 per share. The recent price of the company is $27.31. Our model measures the value of USANA Health Sciences from inspecting the company fundamentals such as current valuation of 363.53 M, and Return On Equity of 0.0776 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting USANA Health's valuation include:
Price Book 0.9703 | Enterprise Value | Enterprise Value Ebitda 3.6772 | Price Sales 0.6042 | Forward PE 9.9305 |
Undervalued
Today
Please note that USANA Health's price fluctuation is very steady at this time. Calculation of the real value of USANA Health Sciences is based on 3 months time horizon. Increasing USANA Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since USANA Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of USANA Stock. However, USANA Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.31 | Real 32.88 | Target 51.5 | Hype 27.44 | Naive 24.59 |
The real value of USANA Stock, also known as its intrinsic value, is the underlying worth of USANA Health Sciences Company, which is reflected in its stock price. It is based on USANA Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of USANA Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of USANA Health Sciences helps investors to forecast how USANA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of USANA Health more accurately as focusing exclusively on USANA Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use USANA Health's intrinsic value based on its ongoing forecasts of USANA Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against USANA Health's closest peers. If more than one evaluation category is relevant for USANA Health we suggest using both methods to arrive at a better estimate.
USANA Health Cash |
|
USANA Valuation Trend
Comparing USANA Health's enterprise value against its market capitalization is a good way to estimate the value of USANA Health Sciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
USANA Revenue by Product
USANA Health Total Value Analysis
USANA Health Sciences is at this time estimated to have valuation of 363.53 M with market capitalization of 516.28 M, debt of 23 M, and cash on hands of 246.88 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the USANA Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
363.53 M | 516.28 M | 23 M | 246.88 M |
USANA Health Investor Information
About 42.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.97. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. USANA Health Sciences has Price/Earnings To Growth (PEG) ratio of 0.83. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 23rd of November 2016. USANA Health Sciences may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.1 | 0.1078 |
|
| |||||
| Total Cash From Operating Activities | 73 M | 61 M |
|
| |||||
| Operating Income | 81.1 M | 66.3 M |
|
|
USANA Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. USANA Health has an asset utilization ratio of 114.21 percent. This suggests that the Company is making $1.14 for each dollar of assets. An increasing asset utilization means that USANA Health Sciences is more efficient with each dollar of assets it utilizes for everyday operations.USANA Health Ownership Allocation
USANA Health Sciences secures a total of 18.9 Million outstanding shares. Over half of USANA Health's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Also note that nearly two hundred thirty thousand six hundred thirty-five invesors are currently shorting USANA Health expressing very little confidence in its future performance.USANA Health Profitability Analysis
The company reported the previous year's revenue of 854.5 M. Net Income was 42.06 M with profit before overhead, payroll, taxes, and interest of 693.29 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates USANA Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in USANA Health and how it compares across the competition.
About USANA Health Valuation
The stock valuation mechanism determines USANA Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of USANA Health. We calculate exposure to USANA Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of USANA Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 693.3 M | 485 M | |
| Pretax Profit Margin | 0.11 | 0.10 | |
| Operating Profit Margin | 0.11 | 0.10 | |
| Net Profit Margin | 0.07 | 0.07 | |
| Gross Profit Margin | 0.81 | 0.64 |
USANA Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 19.2 M | |
| Quarterly Earnings Growth Y O Y | -0.737 | |
| Forward Price Earnings | 9.9305 |
USANA Health Current Valuation Indicators
Valuation refers to the process of determining the present value of USANA Health Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value USANA we look at many different elements of the entity such as USANA's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as USANA Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use USANA Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes USANA Health's worth.Complementary Tools for USANA Stock analysis
When running USANA Health's price analysis, check to measure USANA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy USANA Health is operating at the current time. Most of USANA Health's value examination focuses on studying past and present price action to predict the probability of USANA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move USANA Health's price. Additionally, you may evaluate how the addition of USANA Health to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |